Influenza Articles
A recent experiment found offering healthcare providers financial incentives and creating competition by informing clinics how their performance ranked relative to others were effective in increasing influenza (flu) vaccine rates among patients.
A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
A new study that looked at how the influenza (flu) virus escapes antibodies found the site of the escape mutation varies among most individuals’ sera.
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
A trial was conducted to assess the safety and efficacy of hIVIG (in conjunction with standard care) in adults hospitalized with laboratory-confirmed influenza A or B infection.
The 2018-19 influenza (flu) season was both the longest in a decade and marked by two separate waves of influenza A, CDC says.
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
Researchers at the University of Melbourne have discovered immune cells that can fight all different kinds of the influenza (flu) virus.
A new study conducted by investigators at the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute in Wisconsin has found the flu vaccine does not cause miscarriages in pregnant women.
The WHO advisory board issued its new recommendations on the composition of the influenza vaccines for use in the 2019-20 flu season in the Northern Hemisphere.
A recent meta-analysis of pooled individual patient-level data, researchers found reduced effectiveness of the quadrivalent live-attenuated influenza vaccine (LAIV4) against influenza A/H1N1pdm09 compared with inactivated influenza vaccine (IIV) in children and adolescents.
